Press Release/Announcement

Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors.

US Food and Drug Administration; FDA.

This session kicks off an FDA initiative to redesign drug labeling in an effort to prevent medication errors and develop policies to support the changes. The opportunity to submit comments based on materials discussed at the session has passed.